Hint mode is switched on Switch off
For swift navigation between sections

ISU Abxis

PDF download

Choose all Reset all
Download Cancel
Organization name
ISU Abxis Co., Ltd.
Country name
Republic of Korea
Country of registration
-
Industry
Miscellaneous Healthcare: Products and Services
Public debt
29 mln USD
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

ISU ABXIS Co., Ltd. develops therapeutic antibodies for such as antithrombus, anti-inflammatory, anti-cancer, and rare diseases. The Company also provides medical service such as anti-cancer drug sensitivity examination and gene examination.

Awards

News

27/12/2023 New issue: Issuer ISU ABXIS issued bonds (KR6086891DC9) with the coupon rate of 3% in the amount of KRW 50000000 mln maturing in 2026
All organization news

Documentation

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • SIC
    2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • NACE
    *** ***
  • NAICS
    *** ***
  • Business registration number
    110-81-50558
Registration is required to get access.